 
|
Pancreatic Cancer News and Archives
For access to the
Select Abstractssm section, please click here
For educational purposes
only; not to be relied upon. Please read Pancreatica Disclaimer
- 2006
Second Quarter
-
- Dose-Intense PEFG (Cisplatin,
Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic
Adenocarcinoma
- June 29, 2006
- ...more
-
- Perioperative CA19-9 Levels
can Predict Stage and Survival in Patients with Resectable Pancreatic
Adenocarcinoma
- June 20, 2006
- ...more
-
- Phase I and Pharmacokinetic
Study of S-1 Administered for 14 Days in a 21-Day Cycle in Patients
with Advanced Upper Gastrointestinal Cancer
- June 20, 2006
- ...more
-
- A Case of Recurrent Pancreatic
Cancer Responding to TS-1 Combined Gemcitabine Chemotherapy after
UFT Combined Gemcitabine Chemotherapy Resulting Progressive Disease
- June 1, 2006
- ...more
-
- A Phase II Trial of Irinotecan
and Cisplatin in Patients with Metastatic Neuroendocrine Tumors
- June 1, 2006
- ...more
-
- Combination Chemotherapy
with Gemcitabine and S-1 for Advanced Pancreatic Cancer
- June 1, 2006
- ...more
-
- Pancreatic Anastomotic Leak
after the Whipple Procedure is Reduced Using the Surgical Microscope
- June 1, 2006
- ...more
-
- Survivin Expression in Pancreatic
Intraepithelial Neoplasia (Panin): Steady Increase along the
Developmental Stages of Pancreatic Ductal Adenocarcinoma
- June 1, 2006
- ...more
-
- S-1 Monotherapy For Pancreatic
Cancer
- June 1, 2006
- ...more
-
- A Phase I/II Multicentric
Trial of Gemcitabine and Epirubicin in Patients with Advanced
Pancreatic Carcinoma
- May 23, 2006
- ...more
-
- Epidermal Growth Factor Receptor
Expression in Pancreatic Carcinoma Using Tissue Microarray Technique
- May 23, 2006
- ...more
-
- Phase II Trial of Oral S-1
Combined with Gemcitabine in Metastatic Pancreatic Cancer
- May 23, 2006
- ...more
-
- Helicobacter Species Ribosomal
DNA in the Pancreas, Stomach and Duodenum of Pancreatic Cancer
Patients
- May 21, 2006
- ...more
-
- Combination Therapy of Human
Pancreatic Cancer Implanted in Nude Mice by Oral Fluoropyrimidine
Anticancer Agent (S-1) with Interferon-Alpha
- May 13, 2006
- ...more
-
- A Phase II Trial of Epothilone
B Analogue BMS-247550 (NSC #710428) Ixabepilone, in Patients
with Advanced Pancreas Cancer: A Southwest Oncology Group Study
- May 11, 2006
- ...more
-
- Major Combined Electrolyte
Deficiency During Therapy with Low-Dose Cisplatin, 5-Fluorouracil
and Interferon Alpha: Report on Several Cases and Review of the
Literature
- May 10, 2006
- ...more
-
- Phase I Study of the Humanised
Anti-EGFR Monoclonal Antibody Matuzumab (EMD 72000) Combined
with Gemcitabine in Advanced Pancreatic Cancer
- May 8, 2006
- ...more
-
- Unfavourable Prognosis Associated
with K-Ras Gene Mutation in Pancreatic Cancer Surgical Margins
- May 8, 2006
- ...more
-
- Screening for Early Pancreatic
Neoplasia in High-Risk Individuals: A Prospective Controlled
Study
- May 5, 2006
- ...more
-
- Is Adjuvant 5-FU-Based Chemoradiotherapy
for Resectable Pancreatic Adenocarcinoma Beneficial? A Meta-Analysis
of an Unanswered Question
- May 1, 2006
- ...more
-
- Liposomal Cisplatin Combined
with Gemcitabine in Pretreated Advanced Pancreatic Cancer Patients:
A Phase I-II Study
- May 1, 2006
- ...more
-
- Management of Pancreatic
Endocrine Tumors in Multiple Endocrine Neoplasia Type 1
- May 1, 2006
- ...more
-
- Phase I Study of Biweekly
Gemcitabine Followed by Oxaliplatin and Simplified 48-H Infusion
of Fluorouracil/Leucovorin for Advanced Pancreatic Cancer
- May 1, 2006
- ...more
-
- Therapeutic Options for Gastrointestinal
Carcinoids
- May 1, 2006
- ...more
-
- Gastrazole (JB95008), A Novel
CCK2/Gastrin Receptor Antagonist, in the Treatment of Advanced
Pancreatic Cancer: Results From Two Randomised Controlled Trials
- April 24, 2006
- ...more
-
- Adjuvant Intra-Arterial 5-Fluoruracil,
Leucovorin, Epirubicin and Carboplatin with or without Systemic
Gemcitabine after Curative Resection for Pancreatic Adenocarcinoma
- April 22, 2006
- ...more
-
- Nitric Oxide-Donating Aspirin
Prevents Pancreatic Cancer in a Hamster Tumor Model
- April 15, 2006
- ...more
-
- Roles of Nitric Oxide Synthase
Inhibition and Vascular Endothelial Growth Factor Receptor-2
Inhibition on Vascular Morphology and Function in an in Vivo
Model of Pancreatic Cancer
- April 15, 2006
- ...more
-
- Aggresome Disruption: A Novel
Strategy to Enhance Bortezomib-Induced Apoptosis in Pancreatic
Cancer Cells
- April 1, 2006
- ...more
-
- Intraductal Papillary Mucinous
Neoplasms of the Pancreas: Effect of Invasion and Pancreatic
Margin Status on Recurrence and Survival
- April 1, 2006
- ...more
-
- Maintenance Chemotherapy
after Chemoradiation Improves Survival of Patients with Locally
Advanced Pancreatic Carcinoma: A Retrospective Analysis of Prospectively
Recruited Patients
- April 1, 2006
- ...more
-
- Multicenter Phase-I/II Study
Using a Combination of Gemcitabine and Docetaxel in Metastasized
and Unresectable, Locally Advanced Pancreatic Carcinoma
- April 1, 2006
- ...more
-
- Prospects for Vaccine Therapy
for Pancreatic Cancer
- April 1, 2006
- ...more
-
- Synergistic Antitumor Effects
of Combined Epidermal Growth Factor Receptor and Vascular Endothelial
Growth Factor Receptor-2 Targeted Therapy
- April 1, 2006
- ...more
-
- Survival and Response After
Peptide Receptor Radionuclide Therapy with [90Y-DOTA0,Tyr3]octreotide
in Patients with Advanced Gastroenteropancreatic Neuroendocrine
Tumors
- April 1, 2006
- ...more
-
- The Argument for Pre-Operative
Chemoradiation for Localized, Radiographically Resectable Pancreatic
Cancer
- April 1, 2006
- ...more
-
- Transforming Growth Factor
Alpha Expression Drives Constitutive Epidermal Growth Factor
Receptor Pathway Activation and Sensitivity to Gefitinib (Iressa)
in Human Pancreatic Cancer Cell Lines
- April 1, 2006
- ...more
-
- Venous Resection in Pancreatic
Cancer Surgery
- April 1, 2006
- ...more
-
- What's New in Pancreatic
Cancer Treatment Pipeline?
- April 1, 2006
- ...more
|
